D. Natale
About
D. Natale is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Hepatology.
According to data from OpenAlex, D. Natale has authored 22 papers receiving a total of 326 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 9 papers in Pulmonary and Respiratory Medicine and 5 papers in Hepatology. Recurrent topics in D. Natale's work include Colorectal Cancer Treatments and Studies (12 papers), Cancer Treatment and Pharmacology (10 papers) and Gastric Cancer Management and Outcomes (6 papers). D. Natale is often cited by papers focused on Colorectal Cancer Treatments and Studies (12 papers), Cancer Treatment and Pharmacology (10 papers) and Gastric Cancer Management and Outcomes (6 papers). D. Natale collaborates with scholars based in Italy, United Kingdom and Argentina. D. Natale's co-authors include B. Massidda, Luigi Maiorino, A. Farris, Salvatore Tafuto, Pasquale Comella, Vito Lorusso, Antonio Gambardella, Gianfranco Filippelli, S. Palmeri and Silvana Leo and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.
In The Last Decade
D. Natale
22 papers receiving 315 citations
Peers
D. Natale
S. Fava Italy
Angela Pang Singapore
L. E. James United Kingdom
Hyunho Kim South Korea
Tim R. de Back Netherlands
Yoshinori Takeda Japan
Yingping Cao China
Henrik Hjalgrim Denmark
Osamu Nakahara Japan
Joo Young Jung South Korea
Citations per year, relative to D. Natale D. Natale (= 1×)
peers
S. Fava
Countries citing papers authored by D. Natale
Since
Specialization
Citations
This map shows the geographic impact of D. Natale's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Natale with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Natale more than expected).
Fields of papers citing papers by D. Natale
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by D. Natale. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Natale. The network helps show where D. Natale may publish in the future.
Co-authorship network of co-authors of D. Natale
This figure shows the co-authorship network connecting the top 25 collaborators of D. Natale. A scholar is included among the top collaborators of D. Natale based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Natale. D. Natale is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Formica, Vincenzo, Maria Teresa Ionta, B. Massidda, et al.. (2017). Predictive factors for 6 vs 12 cycles of Folfiri-Bevacizumab in metastatic colorectal cancer. Oncotarget. 9(2). 2876–2886.
2.
Comella, Pasquale, B. Massidda, D. Natale, et al.. (2011). Efficacy and Tolerability of Biweekly Bevacizumab, Irinotecan, Folinic Acid and Fluorouracil Intravenous Bolus (BIFF Regimen) in Patients With Metastatic Colorectal Cancer: The Southern Italy Cooperative Oncology Group Experience. Clinical Colorectal Cancer. 10(1). 42–47.
3.
Comella, Pasquale, B. Massidda, Gianfranco Filippelli, et al.. (2008). Randomised trial comparing biweekly oxaliplatin plus oral capecitabine versus oxaliplatin plus i.v. bolus fluorouracil/leucovorin in metastatic colorectal cancer patients: results of the Southern Italy Cooperative Oncology study 0401. Journal of Cancer Research and Clinical Oncology. 135(2). 217–226.
4.
Comella, P., B. Massidda, Gianfranco Filippelli, et al.. (2007). 3044 POSTER Capecitabine or Folinic acid/Fluorouracil i.v. bolus plus Eloxatin evaluation (COFFE trial) in metastatic colorectal carcinoma (MCRC): final results of the Southern Italy Cooperative Oncology Group (SICOG) phase III trial 0401. European Journal of Cancer Supplements. 5(4). 248–249.
5.
Pignata, Sandro, Giovanni Scambia, Antonella Savarese, et al.. (2006). Safety of a 3-weekly schedule of carboplatin plus pegylated liposomal doxorubicin as first line chemotherapy in patients with ovarian cancer: preliminary results of the MITO-2 randomized trial. BMC Cancer. 6(1). 202–202.
6.
Comella, P., Gianfranco Filippelli, B. Massidda, et al.. (2006). Efficacy of the combination of cisplatin with either gemcitabine and vinorelbine or gemcitabine and paclitaxel in the treatment of locally advanced or metastatic non-small-cell lung cancer: a phase III randomised trial of the Southern Italy Cooperative Oncology Group (SICOG 0101). Annals of Oncology. 18(2). 324–330.
7.
Sandomenico, Claudia, Gianfranco Filippelli, B. Massidda, et al.. (2006). Biweekly oxaliplatin plus capecitabine (OXXEL) versus oxaliplatin plus folinic acid-modulated 5-fluorouracil i.v. bolus (OXAFAFU) in metastatic colorectal carcinoma (MCC): Safety interim analysis of a Southern Italy Cooperative Oncology Group (SICOG) phase III trial. Journal of Clinical Oncology. 24(18_suppl). 3590–3590.
8.
Comella, Pasquale, D. Natale, A. Farris, et al.. (2005). Capecitabine plus oxaliplatin for the first‐line treatment of elderly patients with metastatic colorectal carcinoma. Cancer. 104(2). 282–289.
9.
Comella, P., B. Massidda, S. Palmeri, et al.. (2005). Biweekly oxaliplatin combined with oral capecitabine (OXXEL regimen) as first-line treatment of metastatic colorectal cancer patients: a Southern Italy Cooperative Oncology Group phase II study. Cancer Chemotherapy and Pharmacology. 56(5). 481–486.
10.
Massidda, B., Gianfranco Filippelli, S. Palmeri, et al.. (2005). Oxaliplatin plus high-dose folinic acid and 5-fluorouracil i.v. bolus (OXAFAFU) versus irinotecan plus high-dose folinic acid and 5-fluorouracil i.v. bolus (IRIFAFU) in patients with metastatic colorectal carcinoma: a Southern Italy Cooperative Oncology Group phase III trial. Annals of Oncology. 16(6). 878–886.
11.
Comella, Pasquale, B. Massidda, Gianfranco Filippelli, et al.. (2005). Safety and Efficacy of Irinotecan plus High-Dose Leucovorin and Intravenous Bolus 5-Fluorouracil for Metastatic Colorectal Cancer: Pooled Analysis of Two Consecutive Southern Italy Cooperative Oncology Group Trials. Clinical Colorectal Cancer. 5(3). 203–210.
12.
Pozzi, Samantha, Raffaella Marcheselli, Stefano Sacchi, et al.. (2005). Analysis of Frequency and Risk Factors for Developing Bisphosphonate Associated Osteonecrosis of the Jaw.. Blood. 106(11). 5057–5057.
13.
Buzzi, Franco, D. Natale, A. Farris, et al.. (2005). Capecitabine (XEL) plus oxaliplatin (OX) tailored regimen for the first-line treatment of elderly patients (pts) with metastatic colorectal cancer (MCC). Final results of the Southern Italy Cooperative Oncology Group (SICOG) trial 0108. Journal of Clinical Oncology. 23(16_suppl). 3582–3582.
14.
Comella, Pasquale, Antonio Gambardella, A. Farris, et al.. (2004). A tailored regimen including capecitabine and oxaliplatin for treating elderly patients with metastatic colorectal carcinoma. Critical Reviews in Oncology/Hematology. 53(2). 133–139.
15.
Comella, P., B. Massidda, Gianfranco Filippelli, et al.. (2004). Oxaliplatin (OXA) plus folinic acid (FA) and 5-fluorouracil (FU) i.v. bolus (OXAFAFU) versus irinotecan (IRI) plus FA and FU i.v. bolus (IRIFAFU) in advanced colorectal carcinoma (ACC): Activity and toxicity results of the SICOG 0103 randomized trial. Journal of Clinical Oncology. 22(14_suppl). 4143–4143.
16.
Aricò, Maurizio, Grazia Bossi, R Schirò, et al.. (1994). Juvenile chronic myelogenous leukemia: report of the Italian Registry. Associazione Italiana di Ematologia Oncologia Pediatrica (AIEOP).. PubMed. 78(5). 264–9.
17.
Fioritoni, Giuseppe, A Iacone, D. Natale, et al.. (1992). Randomized Comparison of Ceftriaxone versus Cefriaxone plus Amikacin for the Empirical Treatment of Infections in Patients with Altered Host Defense: Microbiological and Clinical Evaluation. Chemotherapy. 38(6). 420–427.
18.
Iacone, A, Domenico D’Antonio, Alfredo Dragani, et al.. (1990). Autologous blood stem cell transplantation as intensive consolidation therapy in hematological malignancies.. PubMed. 75 Suppl 1. 60–4.
19.
Palka, Giandomenico, Paolo Di Bartolomeo, A Iacone, et al.. (1986). Cytogenetics and bone marrow transplantation. Cancer Genetics and Cytogenetics. 21(2). 147–157.
20.
Gliedman, Marvin L., D. Natale, Harold Rifkin, et al.. (1975). Clinical segmental pancreatic transplantation with ureter-to-pancreatic duct anastomosis for exocrine drainage.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 34(1). 15–20.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by S. Fava Breakdown of academic impact, for papers by Angela Pang Breakdown of academic impact, for papers by L. E. James Breakdown of academic impact, for papers by Hyunho Kim Breakdown of academic impact, for papers by Tim R. de Back Breakdown of academic impact, for papers by Yoshinori Takeda Breakdown of academic impact, for papers by Yingping Cao Breakdown of academic impact, for papers by Henrik Hjalgrim Breakdown of academic impact, for papers by Osamu Nakahara Breakdown of academic impact, for papers by Joo Young Jung